Animal-Assisted Interactions in Children With Life-Threatening Conditions and Their Parents
Status: | Not yet recruiting |
---|---|
Conditions: | Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 3 - 17 |
Updated: | 2/23/2019 |
Start Date: | March 2019 |
End Date: | May 2022 |
Contact: | Maryjo Gilmer |
Email: | maryjo.gilmer@Vanderbilt.Edu |
Phone: | 800-811-8480 |
Effects of Animal-Assisted Interactions (AAI) on Quality of Life in Children With Life-Threatening Conditions and Their Parents
This study will evaluate the effects of animal-assisted interactions (AAI) on stress,
anxiety, and quality of life in children with a life-threatening condition and their parents.
It is anticipated to be a milestone in understanding the human-animal bond.
anxiety, and quality of life in children with a life-threatening condition and their parents.
It is anticipated to be a milestone in understanding the human-animal bond.
Objectives:
1. Examine the feasibility of animal-assisted interactions sessions for children with a
life-threatening condition and primary caregiver to:
- Identify and document modifications for a safe and feasible intervention,
- Obtain recruitment estimates and determine potential recruitment barriers
- Evaluate elements of implementation fidelity (design, training, delivery/receipt of
Treatment, enactment)
- Verify safety.
H1-1: Children and parents (>60%) will complete the interventions and provide positive
acceptability data. H1-2: Implementation fidelity can be achieved with the proposed
methodology
2. Determine the preliminary efficacy of animal-assisted interactions sessions for:
- Children with a life-threatening condition (LTC) for the outcome of health-related
quality of life
- Children with a LTC and their primary caregivers for the outcomes of stress and
anxiety
H2-1 Children with a life-threatening condition who receive animal-assisted interactions will
experience improved health-related quality of life (HRQOL) more than patients who do not
receive animal-assisted interactions.
H2-2a Children with life-threatening condition who receive animal-assisted interactions will
experience decreased stress and anxiety more than parents of children who do not receive
animal-assisted interactions.
H2-2b Primary caregivers of children with a life-threatening condition who receive
animal-assisted interactions will experience decreased stress and anxiety more than parents
of children who do not receive animal-assisted interactions.
1. Examine the feasibility of animal-assisted interactions sessions for children with a
life-threatening condition and primary caregiver to:
- Identify and document modifications for a safe and feasible intervention,
- Obtain recruitment estimates and determine potential recruitment barriers
- Evaluate elements of implementation fidelity (design, training, delivery/receipt of
Treatment, enactment)
- Verify safety.
H1-1: Children and parents (>60%) will complete the interventions and provide positive
acceptability data. H1-2: Implementation fidelity can be achieved with the proposed
methodology
2. Determine the preliminary efficacy of animal-assisted interactions sessions for:
- Children with a life-threatening condition (LTC) for the outcome of health-related
quality of life
- Children with a LTC and their primary caregivers for the outcomes of stress and
anxiety
H2-1 Children with a life-threatening condition who receive animal-assisted interactions will
experience improved health-related quality of life (HRQOL) more than patients who do not
receive animal-assisted interactions.
H2-2a Children with life-threatening condition who receive animal-assisted interactions will
experience decreased stress and anxiety more than parents of children who do not receive
animal-assisted interactions.
H2-2b Primary caregivers of children with a life-threatening condition who receive
animal-assisted interactions will experience decreased stress and anxiety more than parents
of children who do not receive animal-assisted interactions.
Inclusion Criteria:
- Children 3-17 years old
- Confirmed diagnosis of relapsed or refractory cancer
Exclusion Criteria:
- Reported fear or anxiety of dogs (child or parent)
We found this trial at
1
site
Nashville, Tennessee 37232
Principal Investigator: Marjo Gilmer, PhD
Phone: 800-811-8480
Click here to add this to my saved trials